>_ QFI Terminal
Terminal › Stocks › GLAS

Glass House Brands Inc (GLAS) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.90 -3.81%
Last updated Nov 12, 2026 09:30 UTC

GLAS Key Statistics

Market Cap$166.76M
P/E (TTM)-2.92
P/S (TTM)1.02
P/B (TTM)0.91
Revenue (TTM)$163.17M
EPS (TTM)$-0.65
Dividend Yield—
ROE (TTM)-50.85%
Net Margin-31.00%
Gross Margin33.06%
52W High$13.25
52W Low$1.67
Analyst ViewBuy
Price Target$11.00
Employees392
Volume925,912

About Glass House Brands Inc

Glass House Brands, Inc. operates as an integrated cannabis company in the United States with focus on the California market and building brands to serve consumers across various segments. The company is involved in greenhouse cultivation operations, manufacturing practices, brand-building, and retailing activities. The company offers its cannabis products through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell, Forbidden Flowers, and Mama Sue Wellness. The company was founded by Kyle Kazan, Graham Farrar and Jocelyn Rosenwald in 2015 and is headquartered in Long Beach, CA.

CEO: Kyle Kazan. Company website

GLAS — Frequently Asked Questions

What is the GLAS stock price today?

Glass House Brands Inc (GLAS) trades at $1.90, down 3.81% on the day, as of Nov 12, 2026 09:30 UTC.

What is Glass House Brands Inc's market cap?

Glass House Brands Inc has a market capitalisation of $166.76M, calculated from the live GLAS share price and shares outstanding.

What is the P/E ratio of GLAS?

GLAS has no meaningful price-to-earnings ratio: Glass House Brands Inc lost $0.65 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Glass House Brands Inc make?

Glass House Brands Inc generated revenue of $163.17M over the trailing twelve months, which puts the stock at 1.02 times sales.

What is the 52-week range for GLAS?

GLAS has traded between $1.67 and $13.25 over the past 52 weeks, and the last price is 85.7% below that high.

Is Glass House Brands Inc profitable?

No. Glass House Brands Inc is loss-making, with a net margin of -31.00% over the trailing twelve months.

What is the analyst price target for GLAS?

Wall Street analysts rate GLAS Buy, with an average price target of $11.00, 480.5% above the current price.

What sector is Glass House Brands Inc in?

Glass House Brands Inc is classified under the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is domiciled in US.

Who is the CEO of Glass House Brands Inc?

Kyle Kazan is the chief executive of Glass House Brands Inc, which employs 392 people.

Where can I track GLAS in real time?

QFI Terminal shows GLAS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See GLAS live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open GLAS in Terminal See plans

Drug Manufacturers - Specialty & Generic stocks

VTRS Viatris Inc. TEVA Teva Pharmaceutical Industries Limited HLN Haleon plc ZTS Zoetis Inc. ELAN Elanco Animal Health Incorporated PRGO Perrigo Company plc LNTH Lantheus Holdings, Inc. PAHC Phibro Animal Health Corporation PRPH ProPhase Labs, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC NVS Novartis AG SNY Sanofi BMY Bristol-Myers Squibb Company ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc. MOH Molina Healthcare, Inc. AMGN Amgen Inc. MDT Medtronic Plc GSK GSK plc GILD Gilead Sciences, Inc. MDLN Medline Inc. SYK Stryker Corporation DHR Danaher Corporation THC Tenet Healthcare Corporation

Largest institutional holders of GLAS

Park West Asset Management LLC 5,182,030 shares
Western Standard LLC 2,707,101 shares
NOMURA HOLDINGS INC 2,283,439 shares
AdvisorShares Investments LLC 2,255,493 shares
CANTOR FITZGERALD, L. P. 1,350,000 shares
WELLINGTON MANAGEMENT GROUP LLP 1,145,088 shares
Clear Street Group Inc. 825,000 shares
Marex Group Ltd 750,000 shares
Hudson Bay Capital Management LP 750,000 shares
GRIZZLYROCK CAPITAL, LLC 611,000 shares